Australian Pharma Stock News

Global growth is uneven, energy prices remain sensitive to geopolitical shocks, and central banks are weighing inflation against weaker demand. In this kind of cross current, many investors crowd into the same large caps and miss smaller companies with solid balance sheets and resilient business models. The High-Quality Undiscovered Gems screener focuses on exactly those stocks, aiming to surface under-owned opportunities with strong fundamentals while big institutions look elsewhere. This...

Multiple insiders secured a larger position in Gateway Mining Limited ( ASX:GML ) shares over the last 12 months. This...

Sunshine Metals Limited ( ASX:SHN ) shareholders (or potential shareholders) will be happy to see that insider Antonio...

Transurban Group previously announced a cash distribution of A$0.35 per stapled security for the six months ended 30 June 2026, with securities trading ex-distribution on 29 June 2026, a record date of 30 June 2026 and payment scheduled for 18 August 2026. This higher distribution underlines the importance of cash returns in Transurban’s total shareholder proposition, especially given its capital-intensive toll road portfolio. We’ll now examine how this higher A$0.35 distribution shapes the...

Why Liontown Shares Are Back in Focus Recent commentary has pushed Liontown (ASX:LTR) back into the spotlight as lithium recovery discussions gather pace and investors revisit battery material stocks with an eye on funding, offtake agreements, and project execution. This renewed attention places Liontown alongside other ASX lithium companies being assessed on project credibility rather than short term price momentum, which matters if you are weighing long term exposure to the spodumene...

Some of the losses seen by insiders who purchased AU$2.34m worth of Lakes Blue Energy NL ( ASX:LKO ) shares over the...

Potential Janus Electric Holdings Limited ( ASX:JNS ) shareholders may wish to note that insider Peter Koller recently...

In recent days, ANZ Group Holdings has drawn attention as it progresses the Suncorp Bank integration, advances digital banking initiatives, and responds to evolving Australian regulatory settings, while also appointing experienced banker Rachel Slade as a future Non-Executive Director. Together, these developments highlight how ANZ is reshaping its mortgage and retail banking footprint, governance depth, and technology capabilities, which could influence how investors assess its long-term...

Catalyst Metals recently reported record FY26 gold production of 104,000 ounces from the Plutonic Gold Belt, meeting guidance and supported by a strong A$323,000,000 cash and bullion position plus an undrawn A$100,000,000 facility. The company is advancing three new mines, including the Trident underground project expected to add materially to quarterly output, aiming to extend mine life beyond 10 years and lift reserves toward two million ounces. We’ll now examine how Catalyst Metals’...

Recent trading in PLS Group (ASX:PLS) has been shaped by UBS lowering its outlook on the stock, ongoing discussion around production guidance and project spending, and shifting sentiment toward the lithium sector. See our latest analysis for PLS Group. Despite the latest A$5.23 close and 1-day share price return of 1.95%, PLS Group’s 30-day share price return is down 18.66%, while the 1-year total shareholder return is 245.21%, suggesting near term momentum has cooled compared with stronger...

Orica (ASX:ORI) has confirmed it will proceed with a commercial scale green hydrogen facility in the Hunter Valley, aiming to cut emissions by partially replacing natural gas feedstock within its existing operations. See our latest analysis for Orica. Orica's green hydrogen decision comes after a period where short term share price momentum has picked up, with a 90 day share price return of 18.56%, while the 1 year and 5 year total shareholder returns of 25.56% and 105.89% point to stronger...

Why JB Hi-Fi is back in focus for dividend investors JB Hi-Fi (ASX:JBH) is back on investors’ radar after recent coverage highlighted its dividend appeal alongside resilient sales, even as rising supplier costs and stronger competition keep retail sector margins under scrutiny. This renewed attention comes as income-focused investors weigh JB Hi-Fi’s cash flow profile and dividend record in the context of questions about discretionary spending, household budgets and the extent to which...

Champion Iron (ASX:CIA) is drawing fresh attention after announcing the first production of direct reduction (DR) quality iron ore at its Bloom Lake DRPF Project, alongside preparations for an inaugural large-scale commercial shipment. See our latest analysis for Champion Iron. These DR production milestones come after a period where Champion Iron's share price has fallen 24.1% over 90 days and 34.1% year to date, while the 1 year total shareholder return is down 7.3%. This suggests that...

In late June 2026, Mesoblast received a Biologics License Application filing number from the U.S. FDA and requested modular review for rexlemestrocel-L to prevent life-threatening gastrointestinal bleeding in end-stage heart failure patients supported by left ventricular assist devices, building on its Orphan Drug and RMAT designations. The filing comes as new FDA draft guidance reiterates a flexible approach to therapies for rare, high-mortality conditions, potentially aligning closely with...

PEXA Group recently announced a leadership reshuffle in its UK business, appointing Krystle Kocik and Simon Wright as Co-CEOs, alongside adding two independent non-executive directors, Janelle Hopkins and John Hooper, to its board. These leadership and governance changes, combined with PEXA’s engagement on IPART’s draft review of ELNO service fees, could reshape how investors assess its UK expansion and regulatory risk profile. We’ll now examine how the new Co-CEO structure in PEXA UK may...

Arafura Rare Earths (ASX:ARU) has attracted fresh attention after signing a binding term sheet to supply neodymium praseodymium oxide, and is moving toward final funding approvals and imminent construction at its Nolans Project. See our latest analysis for Arafura Rare Earths. At a share price of A$0.25, Arafura Rare Earths has seen a 7 day share price return of 6.38%, while the 30 day and 90 day share price returns are down 10.71% and 16.67% respectively. Over a longer period, the 1 year...

Xero Limited recently launched Industry Benchmarks in Xero Analytics and rolled out a Microsoft 365 integration that brings real-time Xero financial data and its JAX AI assistant into Microsoft 365 Copilot and core Office apps. Together, these moves deepen Xero’s AI capabilities and embed its platform inside widely used productivity tools, potentially changing how small businesses and advisors run and interpret their finances day to day. Next, we’ll examine how this deeper Microsoft 365...

Founder-led stocks can offer something many investors look for, especially when global data feels mixed on growth, inflation, and policy direction. With services sectors holding up in several regions, inflation showing pockets of relief, and energy and geopolitical risks still in focus, commitment at the top of a company can matter even more. The Top Founder-Led Companies screener focuses on leaders with meaningful skin in the game and strong capital efficiency, so you are not just backing a...

AI is no longer just a big tech story. While global data points show mixed growth, cooling inflation in some regions and a steady recovery in services and manufacturing, smaller AI-focused companies are quietly building tools in machine learning, automation, and data intelligence that aim to solve very specific problems. That is where the AI Small Caps screener comes in. It helps you filter for early-stage opportunities that might otherwise be buried under the headlines about mega caps. In...

Elevra Lithium has completed the groundbreaking of its North American Lithium Expansion project, following a May 2026 capital raise that fully funded Stage 1 and allowed equipment orders to support its planned development timeline. By targeting a 15–20% uplift in spodumene concentrate capacity and lower unit operating costs, the expansion underlines Elevra Lithium’s push to supply more traceable lithium to electric vehicle and energy storage customers. Next, we’ll examine how fully funded...

Gold mining stocks are back in focus after a key shift in the macro backdrop. Softer U.S. jobs data, reduced expectations for further Federal Reserve rate hikes and renewed central bank demand for bullion have all supported gold prices, giving fresh attention to companies that pull the metal out of the ground. For investors, that combination can change how risk and reward stack up across gold mining stocks screened for financial strength and specific country exposure. This article looks at 3...

In recent weeks, Evolution Mining has been in focus as gold prices rebounded on a softer US dollar and easing interest-rate expectations, lifting investor attention on the company’s gold and copper exposure. At the same time, investors are increasingly weighing Evolution’s operational quality, cost control and balance sheet strength rather than relying solely on broad gold sector momentum. We’ll now examine how this renewed focus on operational quality amid improving gold prices may...

As the Australian market opens the new financial year flat, with the ASX hovering around 8,780 points, global markets are showing mixed signals amid ongoing geopolitical tensions and tech-driven rallies. In such a landscape, identifying promising investment opportunities requires a keen eye for stocks that balance affordability with potential for growth. Penny stocks, often representing smaller or newer companies, continue to capture investor interest due to their unique blend of...

In the past few days, Cochlear Limited cut its FY26 underlying net profit guidance to A$290 million–A$330 million, citing weaker implant demand in developed markets, Middle East delivery and receivables risk, margin pressure, and higher restructuring costs. This guidance downgrade highlights how operational challenges in key geographies and rising costs can alter expectations for a business often viewed as a core ASX healthcare exposure. We’ll now examine how Cochlear’s reduced FY26 profit...